Type 2 & other diabetes

Simultaneous assessment of stress hyperglycemia ratio and glycemic variability to predict mortality in patients with coronary artery disease: a retrospective cohort study from the MIMIC-IV database

Cardiovasc DiabetolPublished Retrospective cohort study

Authors' conclusion

The simultaneous evaluation of SHR and GV provides more information for risk stratification and prognostic prediction than SHR and GV alone, contributing to developing individualized strategies for glucose management in patients with CAD admitted to the ICU.

Study context

Population
Patients with coronary artery disease (CAD) hospitalized in the intensive care unit (ICU), MIMIC-IV database (version 2.2), 2008–2019; mean age 69.6 years, 30.1% female
Participants
2,789 patients
Exposure
Combined stress hyperglycemia ratio (SHR) and glycemic variability (GV) vs SHR or GV alone for predicting mortality
Outcome
1-year mortality
Follow-up
1 year
Methodological detailsMIMIC-IV database
  • MIMIC-IV database

Main finding

As reported in the abstract

1-year mortality: discrimination (ROC analysis)
Deaths at 1 year
404 (14.5%)
SHR + GV vs SHR alone (ROC)
0.644 vs. 0.615, p = 0.007
SHR + GV vs GV alone (ROC)
0.644 vs. 0.603, p < 0.001
Nondiabetic, high SHR and high GV: greatest risk of 1-year mortality, HR
5.830 (3.175-10.702) (95% CI)
Diabetic, high SHR but low GV: highest risk of 1-year mortality, HR
2.013 (1.224-3.311) (95% CI)

Observational data: associations, not effects.

Secondary outcomes

In-hospital mortality

Deaths in hospital
138 (4.9%)
SHR + GV vs SHR alone (ROC)
0.710 vs. 0.689, p = 0.012
SHR + GV vs GV alone (ROC)
0.710 vs. 0.632, p = 0.004
Nondiabetic, high SHR and high GV: greatest risk, OR
10.831 (4.494-26.105) (95% CI)
Diabetic, high SHR but low GV: highest risk, OR
4.221 (1.542-11.558) (95% CI)

Original publication

Simultaneous assessment of stress hyperglycemia ratio and glycemic variability to predict mortality in patients with coronary artery disease: a retrospective cohort study from the MIMIC-IV database. Cardiovasc Diabetol. Published 9 February 2024. doi:10.1186/s12933-024-02146-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.